Pancreatic Cancer Research

ResearcherAstraZenecaNo recent work listed

BSc, MBCHB, MD Jane Robertson

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers
0
Trials
2
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2007: 1 trial · 2008: none · 2009: none · 2010: 1 trial

Trials 2

  1. Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats Study director NCT01078662↗
  2. Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer Study director NCT00515866↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Bella Kaufman · 1 shared trial, 2010 · strength 0.07
  2. Howard A. Burris · 1 shared trial, 2007 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.